Global Artificial Retina
Market Report
2024
The global Artificial Retina market size is USD 2845.6 million in 2024. The growing number of startups that are involved in the development of artificial retina implants is expected to boost sales to USD 5135.42 million by 2031, with a Compound Annual Growth Rate (CAGR) of 8.80% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Artificial Retina Market Report 2024.
According to Cognitive Market Research, the global Artificial Retina market size will be USD 2845.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.80% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Artificial Retina Market Sales Revenue 2024 | $ 2845.6 Million |
Global Artificial Retina Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.8% |
North America Artificial Retina Market Sales Revenue 2024 | $ 1138.24 Million |
North America Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7% |
United States Artificial Retina Sales Revenue 2024 | $ 898.07 Million |
United States Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.8% |
Canada Artificial Retina Sales Revenue 2024 | $ 136.59 Million |
Canada Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.8% |
Mexico Artificial Retina Sales Revenue 2024 | $ 103.58 Million |
Mexico Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
Europe Artificial Retina Market Sales Revenue 2024 | $ 853.68 Million |
Europe Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.3% |
United Kingdom Artificial Retina Sales Revenue 2024 | $ 143.42 Million |
United Kingdom Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.1% |
France Artificial Retina Sales Revenue 2024 | $ 78.54 Million |
France Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.5% |
Germany Artificial Retina Sales Revenue 2024 | $ 169.03 Million |
Germany Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
Italy Artificial Retina Sales Revenue 2024 | $ 73.42 Million |
Italy Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.7% |
Russia Artificial Retina Sales Revenue 2024 | $ 132.32 Million |
Russia Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.3% |
Spain Artificial Retina Sales Revenue 2024 | $ 70 Million |
Spain Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.4% |
Rest of Europe Artificial Retina Sales Revenue 2024 | $ 132.32 Million |
Rest of Europe Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
Asia Pacific Artificial Retina Market Sales Revenue 2024 | $ 654.49 Million |
Asia Pacific Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.8% |
China Artificial Retina Sales Revenue 2024 | $ 294.52 Million |
China Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.3% |
Japan Artificial Retina Sales Revenue 2024 | $ 90.32 Million |
Japan Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.3% |
Korea Artificial Retina Sales Revenue 2024 | $ 65.45 Million |
Korea Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.9% |
India Artificial Retina Sales Revenue 2024 | $ 78.54 Million |
India Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 12.6% |
Australia Artificial Retina Sales Revenue 2024 | $ 34.03 Million |
Australia Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.5% |
Rest of APAC Artificial Retina Sales Revenue 2024 | $ 46.47 Million |
Rest of APAC Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.6% |
South America Artificial Retina Market Sales Revenue 2024 | $ 142.28 Million |
South America Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.2% |
Brazil Artificial Retina Sales Revenue 2024 | $ 60.9 Million |
Brazil Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.8% |
Argentina Artificial Retina Sales Revenue 2024 | $ 23.9 Million |
Argentina Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.1% |
Colombia Artificial Retina Sales Revenue 2024 | $ 12.66 Million |
Colombia Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8% |
Peru Artificial Retina Sales Revenue 2024 | $ 11.67 Million |
Peru Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.4% |
Chile Artificial Retina Sales Revenue 2024 | $ 10.24 Million |
Chile Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Rest of South America Artificial Retina Sales Revenue 2024 | $ 22.91 Million |
Rest of South America Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.3% |
Middle East and Africa Artificial Retina Market Sales Revenue 2024 | $ 56.91 Million |
Middle East and Africa Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Turkey Artificial Retina Sales Revenue 2024 | $ 4.89 Million |
Turkey Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8% |
Nigeria Artificial Retina Sales Revenue 2024 | $ 5.98 Million |
Nigeria Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.6% |
Egypt Artificial Retina Sales Revenue 2024 | $ 5.98 Million |
Egypt Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.8% |
South Africa Artificial Retina Sales Revenue 2024 | $ 8.99 Million |
South Africa Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.5% |
GCC Countries Artificial Retina Sales Revenue 2024 | $ 24.36 Million |
GCC Countries Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.3% |
Rest of MEA Artificial Retina Sales Revenue 2024 | $ 6.72 Million |
Rest of MEA Artificial Retina Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by Type |
|
Market Split by Disease Indication |
|
Market Split by End-User |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Artificial Retina industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Artificial Retina Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Artificial retina technology seeks to reinstate vision for those afflicted with severe retinal degenerative illnesses by circumventing impaired retinal cells and activating the remaining visual pathways. This groundbreaking approach shows potential for treating illnesses including retinitis pigmentosa and age-related macular degeneration, providing optimism for the restoration of partial vision. The artificial retina market is now seeing significant expansion due to the growing occurrence of retinal illnesses, developments in technology, and increased investments in healthcare. The market's growth is bolstered by continuous research, development endeavors, and rising acceptance of these devices in both developed and emerging regions.
July 2022: Nidek Co., Ltd., a company that manufactures and distributes ophthalmic products, acquired Nidek Medical S.R.L corporation and now holds a 90% stake in the company. This agreement will facilitate enhanced cooperation between Nidek Medical and Nidek, consequently augmenting their overall performance. (Source: https://www.nidek-intl.com/news-event/news/entry-4521.html )
The increasing occurrence of retinal illnesses, such as age-related macular degeneration (AMD) and retinitis pigmentosa, is a major factor contributing to the growth of the worldwide artificial retina market. The demand for enhanced vision restoration technologies is increasing as populations age and chronic illnesses become more prevalent. AMD, a prominent contributor to age-related visual impairment, and retinitis pigmentosa, a progressive disorder impacting a significant number of individuals, underscore the pressing demand for efficacious therapies. Artificial retina implants provide a hopeful answer by circumventing impaired retinal cells and partially reinstating vision, thereby meeting a critical requirement for patients afflicted with these incapacitating illnesses.
The acceleration of improvements in artificial retina technologies is being driven by an increase in investment in research and development (R&D) in the pharmaceutical and medical technology industries. The rise of pioneering startups specializing in artificial retina implants is a crucial catalyst for the expansion of the sector. These startups introduce innovative methods and technological progress, such as enhanced compatibility with living organisms, reduction in size, and the ability to operate without wires. Their contributions facilitate the advancement of more efficient and cost-effective artificial retina solutions, promoting increased competitiveness and innovation in the market. This dynamic setting expedites the process of bringing artificial retina implants to the market and increasing their use by patients globally.
The exorbitant expense associated with artificial retina devices and procedures significantly hinders the expansion of the market. The high cost of these implants can be attributed to the utilization of modern technology, considerable research and development, and the stringent regulatory permissions that are necessary for their production. The exorbitant expense of healthcare restricts its affordability and accessibility, especially in areas with limited healthcare resources and poor socioeconomic status. The broad use of artificial retina technology is facing challenges, particularly in emerging economies where financial restrictions are more prominent. These limits have the potential to hinder the overall growth of the artificial retina market.
The artificial retina market was greatly affected by the COVID-19 pandemic, as it caused disruptions in clinical research, production, and supply chains. Limitations and the allocation of resources caused delays in ongoing clinical trials and temporarily suspended certain efforts. Nevertheless, the market is expected to expand due to the rise in healthcare funding, economic recovery, and the heightened emphasis on ophthalmology. During the projected period, the artificial retina market is predicted to recover and increase because to the return of elective surgeries and anticipated product launches from firms performing clinical trials.
We have various report editions of Artificial Retina Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The Global Artificial Retina Market is distinguished by its competitive landscape, which is characterized by continuous technological advancements and intense competition. In order to introduce innovative artificial retina systems with improved patient outcomes and enhanced functionality, market participants are prioritizing research and development activities. Key actors employ strategic collaborations, partnerships, and acquisitions as prominent strategies to enhance their market presence and diversify their product portfolios.
September 2021: Bionic Vision Technologies (BVT) in Australia collaborated with Cirtec Medical to enhance its bionic eye technology. Cirtec's funding will support the advancement of BVT's state-of-the-art retinal implant. A global pivotal study for the system, which aims to restore vision for the blind, is scheduled for 2022. (Source: https://bionicvis.com/2021/09/06/australias-bionic-eye-advances-due-to-us-partnership/) August 2022: Second Sight Medical Products Inc. (US) announced the successful completion of its merger with Nano Precision Medical Inc. (US) and the subsequent rebranding of the company as Vivani Medical, Inc. (Source: https://vivani.com/second-sight-medical-products-announces-successful-completion-of-its-merger-with-nano-precision-medical-and-its-name-change-to-vivani-medical-inc/)
Top Companies Market Share in Artificial Retina Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024. The artificial retina market in North America is primarily influenced by the significant occurrence of retinal disorders and huge healthcare spending. The quick adoption of cutting-edge technologies is facilitated by the existence of prominent market participants and modern healthcare infrastructure. Moreover, the market growth in this region is further strengthened by advantageous reimbursement policies and regulatory backing.
Asia Pacific stands out as the fastest-growing region in the Artificial Retina market as a result of a sizable and aging population, a heightened awareness of retinal disorders and an increase in healthcare expenditure. The market acceptance and growth are further accelerated by significant developments in healthcare infrastructure and expanding research and development initiatives in nations like India and China.
The current report Scope analyzes Artificial Retina Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1138.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 853.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 654.49 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 142.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031. .
According to Cognitive Market Research, the global Artificial Retina market size was estimated at USD 2845.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 56.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031..
Global Artificial Retina Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Artificial Retina Industry growth. Artificial Retina market has been segmented with the help of its Type, Disease Indication End-User, and others. Artificial Retina market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Artificial Retina Market?
According to Cognitive Market Research, Epiretinal Implants stands out as the dominant category over the projected period. Epiretinal implants employ a thin electrode array to be affixed to the inner surface of the retina, thereby inducing the remaining healthy retinal cells to produce visual signals. Due to its commercial availability of epiretinal prostheses, extensive research, and established clinical efficacy, this segment maintains a substantial market share.
Subretinal Implants emerges as the fastest-growing category in the Artificial Retina market. Subretinal implants circumvent the damaged photoreceptor layer and directly activate retinal cells. This market is growing rapidly due to subretinal implant technologies, excellent clinical trial findings, and the potential to increase visual acuity and patient outcomes. Due to increased research and development into subretinal implant performance and safety, the market is likely to rise significantly.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Artificial Retina Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the dominant category is Age-Related Macular Degeneration (AMD). AMD is a prominent cause of visual loss in older persons, and the desire for effective AMD therapies is driving this segment's rise. Bypassing the injured macula and activating the remaining retinal cells, artificial retina systems may restore vision. AMD dominates the market because to its prevalence, awareness, and diagnostic rates.
The fastest-growing category in the Artificial Retina market is Retinitis Pigmentosa (RP). It's one of the most prevalent hereditary retinal illnesses, thus effective therapies are in need. Modern retinal implants for RP are more effective and accessible, increasing their usage. Research & development, funded by governmental and commercial sources, is also boosting RP solution development. Rapid expansion of RP applications in the artificial retina industry is partly due to patient awareness and activism and favorable regulatory frameworks.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the dominant category is Multi-Specialty Hospitals. Due to their comprehensive facilities, advanced medical apparatus, and capacity to manage intricate surgeries and postoperative care, they have achieved this level of dominance.
The fastest-growing category in the Artificial Retina market is Research Institutes. Increasing attention is being paid to research and development efforts in order to create and enhance artificial retina technology, which is the primary vehicle behind this fast expansion.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Epiretinal Implants, Subretinal Implants, Suprachoroidal Implants, Optogenetic Implants, Others |
Disease Indication | Retinitis Pigmentosa (RP), Age-Related Macular Degeneration (AMD), Stargardt Disease, Others |
End-User | Multi-Specialty Hospitals, Ophthalmic Clinics, Research Institutes |
List of Competitors | Second Sight Medical Products Inc., Pixium Vision, Nano Retina Inc., Retina Implant AG, Bionic Vision Technologies Pty Ltd., VisionCare Inc., iBIONICS, Monash Vision Group, Optobionics Corporation, Biomedical Technologies S.L. |
This chapter will help you gain GLOBAL Market Analysis of Artificial Retina. Further deep in this chapter, you will be able to review Global Artificial Retina Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America Artificial Retina Market Trends North America Artificial Retina Technological Road Map North America Artificial Retina Market Drivers North America Artificial Retina Market Restraints North America Artificial Retina Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Disease Indication Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-User Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Artificial Retina market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Epiretinal Implants have a significant impact on Artificial Retina market? |
What are the key factors affecting the Epiretinal Implants and Subretinal Implants of Artificial Retina Market? |
What is the CAGR/Growth Rate of Retinitis Pigmentosa (RP) during the forecast period? |
By type, which segment accounted for largest share of the global Artificial Retina Market? |
Which region is expected to dominate the global Artificial Retina Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Artificial Retina Market
Request Sample